Showing posts with label Post-traumatic stress disorder. Show all posts
Showing posts with label Post-traumatic stress disorder. Show all posts

Tuesday, June 24, 2008

Helping Women Soldiers Traumatized by Sexual Assault

By Sally Chew

In the past few years there has been a lot of attention paid to the problem of sexual assault in the U.S. military. Congressional hearings, military panels, and nonprofit organizations have looked at how to lower the incidence of assault, help women feel safe reporting it, and allow them to recover from the Post-traumatic stress disorder (PTSD) that often follows it.
A new report from Australia recommends prolonged exposure therapy for preventing PTSD. The treatment involves reliving the traumatic experience with a therapist in order to face your fears and learn coping skills. Last year a study published in the Journal of the American Medical Association (JAMA) recommended the therapy specifically to treat women vets with PTSD—a condition they are more likely to report suffering from than men. Read More

Friday, November 17, 2006

Breast Cancer Diagnosis Brings Serious Distress

(HealthDay News) -- Nearly half of women newly diagnosed with breast cancer undergo clinically significant emotional distress or symptoms of psychiatric disorders such as depression and Post-traumatic stress disorder (PTSD), new research shows.

In many cases, the women's psychological troubles aren't noted by doctors or aren't adequately treated, the study authors added.

The study included 236 women newly diagnosed with breast cancer who had not yet started cancer treatment.

Forty-seven percent underwent significant distress following their diagnosis, the U.S. team found. The most common problem was moderate to severe emotional distress (41 percent). The most commonly cited sources for that distress were the cancer diagnosis (100 percent), uncertainty about treatment (96 percent), and worries about physical problems (81 percent).
The researchers also found that 21 percent of the women met criteria for psychiatric disorders, including major depression (11 percent) and PTSD (10 percent). These disorders were linked to major declines in the women's daily functioning.

Many of the women with depression were already taking antidepressants but continued to have significant depression symptoms. This suggests that even when they're identified as being depressed, newly-diagnosed breast cancer patients may be undertreated, the study authors said.

"This study has at least two important implications," researcher Mark T. Hegel, of the department of psychiatry and the Norris Cotton Cancer Center at Dartmouth Medical School in New Hampshire, said in a prepared statement.

"First, we need to do a better job of getting the word out about how well we can treat breast cancer," he said. "These emotional disorders are almost certainly due in part to the fear and helplessness that continues to result from receiving a cancer diagnosis.

Second, we need to assess for and provide adequate intervention for the women meeting criteria for these severe but very treatable psychiatric conditions."

More information
Breastcancer.org offers advice on dealing with breast cancer fears.

Thursday, September 21, 2006

Brain Helps Keep Emotions at Bay

(HealthDay News) -- A new study may reveal how people function amidst distracting emotions.

Published in the Sept. 21 issue of Neuron, the findings suggest the human brain is able to prevent emotions from interfering with mental functioning.

Researchers from Columbia University Medical Center in New York City asked volunteer participants to indicate by pressing a button whether a face image was happy or fearful, while ignoring "fear" and "happy" labels written across each face.

The labels were either "congruent" (e.g., happy face, "happy" label) or "incongruent" (e.g., happy face, "fear" label). The incongruent labels were designed to represent a conflict between emotional and cognitive stimuli.

During the tests, the researchers used functional magnetic resonance imaging to determine what parts of the brain were active.

They found that when the participants were exposed to the incongruent labels, activity of the amygdala -- the brain's center for processing emotional events -- was inhibited by the anterior cingulated cortex -- the brain's center for neural processing.

The researchers speculated that their findings may help explain why people who suffer from post-traumatic stress disorder (PTSD) or depression may be unable to control emotional intrusion into their thoughts. They pointed out that the brains of people with PTSD and depression may be less able to inhibit the amygdala during emotional processing.

More information
The National Institute of Mental Health has more about Post-traumatic stress disorder PTSD.

Monday, September 11, 2006

Health Highlights: Sept. 10, 2006

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:
Ibuprofen Can Lessen Aspirin's Cardiovascular Benefits, FDA Says

Taking the pain relievers aspirin and ibuprofen at the same time may lessen aspirin's effects in preventing a heart attack, a U.S. government agency warns.

The Food and Drug Administration says that combining low dose aspirin (usually 81 mg) with 400 mg of ibuprofen (e.g., Advil, Motrin) reduces the antiplatelet effect on the heart the low dose aspirin provides.

In its Sept. 8 report to consumers, the FDA said there is no evidence that taking the two anti-pain medications is harmful, but that ibuprofen has been shown to reduce aspirin's cardio-protective benefit.

But, says the FDA, you can take the two drugs within a reasonable time of each other, under certain circumstances. The research showed that a person could take ibuprofen 30 minutes after taking aspirin. Or aspirin could be taken 8 hours after taking ibuprofen.

Most important, the agency says, check with your physician, especially if you're taking aspirin as part of a daily heart regimen.
-----
Anti-Inflammatory Drugs Could Cause Damage After Hip Surgery

Anti-inflammatory drugs used six months after hip replacement surgery demonstrate no more pain relief than when they're not used, a new study from Australia and New Zealand says. Furthermore, the use of ibuprofen (e.g., Motrin, Advil) may actually cause unnecessary bleeding, the researchers found.

Scientists from The George Institute for International Health studied post-operative treatment of more than 900 patients, concentrating on the development of ectopic bone formation, which can occur 6-to-12 months after hip surgery. This bone develops in about one-third of hip replacement patients, the researchers say. It forms in soft tissue around the operated hip and can cause inflammation and pain.

While ibuprofen can "greatly reduce" the chances of ectopic bone formation, the scientists, said, it also considerably increases the chance of internal bleeding. And, they note, patients who didn't use ibuprofen reported no greater pain and discomfort 6-to-12 months after surgery than those who used the drug.
-----
Anticipating a Bad Event Can Make the Memory of it Worse, Study Says
Sometimes, too much knowledge can be a dangerous thing.

In a small study, researchers at the University of Wisconsin-Madison have found that being aware that something bad is about to happen is going to make a person remember it more vividly after the event occurs.

BBC News reports that the study, published in the latest issue of the Proceedings of the National Academy of Sciences journal, found that a part of the brain that triggers memory retention activated when people anticipated an adverse event.

Researchers first showed 36 study subjects a series of symbols, followed by pictures depicting gruesome images, BBC news reported. The symbols indicated the subjects either were going to see the bad photos or be spared the experience. The subjects were quizzed 30 minutes after first having seen the pictures and again two weeks later.

The scientists concluded that those who saw the gruesome images were more likely to remember them more vividly than those who saw benign material. "Our study illustrates how the power of expectancy can extend to memory formation as well, the BBC quotes lead author Jack Nitschke as saying. "Just the expectation of seeing something bad can enhance the memory of it after it happens."

The research may be used in developing ways to treat post traumatic stress disorder, the researchers say.
-----
Polio Vaccination Effort Begins in Parts of Africa
Attempting to counter claims by some Islamic clerics that the polio vaccine is part of a U.S. plot, officials from the World Health Organization (WHO) have embarked on a campaign to immunize almost 3 million children in the Horn of Africa this year against polio.

According to the Associated Press, the crippling disease has re-emerged in parts of Africa in recent years, and WHO officials are targeting children under 5-years-old in Somalia, Kenya and Ethiopia. According to the health organization, Somalia has reported 215 cases, Ethipia has 37 reported cases since 2004, and Kenya has had no reported cases in 22 years.

The problem is that many people in Africa are nomadic, so the possibility of polio spreading is a real threat, the wire service reports. "Nomadic people move between these countries all the time, so the idea is to try to get to these children and protect them," the A.P. quotes Dr. Mohamed Dahir Duale, a Kenya-based doctor with WHO, as saying.

In 2003 some radical Islamic clerics claimed that the polio vaccine, first developed Dr. Jonas Salk in the United States in the 1950s, was part of a U.S.-led plot to render Nigeria's Muslims infertile or infect them with AIDS. The vaccination program was stopped for more than a year, and cases of polio began to appear.
-----
Major Changes in NYC Healthcare Use After 9/11: Study
There was a sharp decline in healthcare usage in the New York City region during the three weeks after the Sept. 11 terrorist attacks, but usage then rose above expected levels over the following months, concludes a study in the September issue of the journal Biosecurity and Bioterrorism.

Researchers analyzed health insurance claims from January 2000 to March 2002 for more than two million residents of the New York City region.

The greatest decline in healthcare usage in the weeks after Sept. 11 was among people who lived closest to the World Trade Center (WTC) site. For example, there was an overall 11 percent decline in visits to doctors' offices in the three weeks after 9/11, but a 15 percent decline in office visits by people who lived within a 10-mile radius of the WTC.

The decline in office visits in those first few weeks was likely related to disruptions in access to healthcare services or transportation, the researchers said. In addition, many people may have decided to postpone healthcare visits in order to take care of more immediate issues.

Insurance claims for mental health services were lower than expected for the six months after 9/11. The researchers suggested a number of possible reasons, such people taking advantage of free mental health services, or many not recognizing their need for mental health care. Mental stress may have also manifested as physical illness, which resulted in increased healthcare use for conditions such as chest pain, ulcers, fainting, and irregular heart beats.

Between October 2001 and March 2002, the number of visits to doctors' offices was more than 200,000 over expected levels, the study found.

In related news, residents living near the World Trade Center site said the U.S. federal government has ignored health problems they have suffered as a result of the 9/11 attacks.
At a meeting held Thursday, accountant Tom Goodkind, 52, said that while there are programs for rescue/cleanup workers, little has been done for area residents, the Associated Press reported.

"I don't think that any of these groups have looked at the children of our neighborhoods," Goodkind said.

"Collateral damage, that's what I feel like," said tenant group leader Diane Lapson.
Also on Thursday, the Bush administration said it would provide $75 million for health programs for sick Sept. 11 rescue/cleanup workers.

Saturday, July 22, 2006

Health Highlights: May 23, 2006

Here are some of the latest health and medical news developments, compiled by editors of HealthDay: NSAIDs Increase Risk of 1st Hospital Admission for Heart Failure

Commonly used nonsteroidal anti-inflammatory drug (NSAID) painkillers, such as ibuprofen, are associated with a slightly increased risk of first hospital admission for heart failure, says a study in the journal Heart.

The study of more than 228,660 patients concluded that there would be one extra first hospital admission for heart failure for every 1,000 people ages 60 to 84 who take NSAIDs, United Press International reported.

However, the researchers said this could increase to three additional cases per 1,000 among patients 70 and older who have chronic conditions such as high blood pressure, diabetes, or kidney failure.

Overall, 14 percent of patients were taking NSAIDs at the time of their first hospital admission for heart failure, compared with 10 percent of a comparison group of randomly selected people. Half of those admitted to hospital were ages 70 to 79.

The data used in the study came from the General Practice Research Database, which contains the medical records of millions of patients of family doctors in Britain, UPI reported.
-----
Prince Charles, British Docs Differ Over Alternative Medicine
Just hours after a group of Britain's leading doctors and scientists urged the National Health Service (NHS) to stop paying for complementary health therapies, Prince Charles told a meeting of the World Health Organization in Geneva that alternative medicine should be given more prominence in mainstream health care.

In an open letter, the British doctors and scientists criticized public funding of "unproven or disproved treatments" such as homeopathy and reflexology at a time when large deficits are leading to the firing of nurses and to limited patient access to life-saving drugs, The Times of London reported.

They demanded that the NHS pay only for evidence-based therapies.
In his speech, the Prince of Wales said that an integrated, holistic approach was the best way to tackle chronic disease, rather than a "dangerously fragmented" approach that relies on what he referred to as a bio-physical treatment model, The Times reported.
He did note that modern medicine has served humanity well but he said excessive reliance on it had upset natural harmony.

"I believe there is now a desperately urgent need to address the fragile but vital balance between man and nature, through a more integrated approach where the best of the ancient is blended with the best of the modern, and I am convinced this is particularly vital when it comes to the collective health of people in all countries," Prince Charles told delegates from 192 nations.
-----
No Difference Between 2 Anemia Drugs for Cancer Patients: Report
There is no clinically significant difference in effectiveness between two drugs -- epoetin and darbepoetin -- used to manage anemia in cancer patients undergoing chemotherapy or radiation treatment, says a report released Tuesday by the U.S. Agency for Healthcare Research and Quality (AHRQ).

The report said the two drugs show no difference in improving hemoglobin concentration or in reducing the need for transfusion. Both drugs do reduce the need for transfusion by about 20 percent, but there is no evidence that either drug, when added to cancer treatment, improves patient survival.

In addition, there are many unanswered questions about the safety and best use of both drugs, the report said.

"This report is a synthesis of studies performed so far regarding epoetin and darbepoetin, including unpublished findings as well as published reports," Dr. Carolyn M. Clancy, AHRQ director, said in a prepared statement.

"The authors have analyzed and weighed all of the evidence available in order to obtain the fairest possible understanding of these two alternative treatments for managing anemia in cancer patients. In addition, an important role for our comparative-effectiveness reviews is to identify research gaps where new evidence is needed. Their report finds that significant questions remain unanswered about both of these drugs," Clancy said.
-----
U.S. Soldiers With PTSD More Likely to Suffer Poor Health

A year after leaving Iraq, American combat soldiers with post-traumatic stress disorder (PTSD) are more likely to be in worse physical health, experience more pain, and are more likely to miss work than those who don't have PTSD, says a U.S. military survey of nearly 3,000 Iraq war veterans.

The survey found that about 17 percent of the respondents had PTSD symptoms and they were more likely than those without symptoms to report various kinds of pain -- from backaches to headaches -- and gastrointestinal problems such as indigestion and nausea, USA Today reported.

Anxiety may contribute to these physical symptoms, said Dr. Charles Hoge, chief of psychiatry and neuroscience at the Walter Reed Army Institute of Research in Washington, D.C.
He also noted that nightmares, flashbacks and other symptoms of PTSD can interfere with sleep, resulting in a negative impact on health. About 50 percent of the soldiers who reported PTSD symptoms rated their health as fair to poor, compared with about 20 percent of soldiers with no PTSD symptoms, USA Today reported.
The findings were released Monday at an American Psychiatric Association meeting.
-----
FDA Approves Generic Version of Lexapro
The first generic version of Lexapro (escitalopram oxalate), one of the most popular prescription antidepressants, has been approved by the U.S. Food and Drug Administration.
The approval, announced Monday, gives permission to Ivax Corp. of Miami to market 5, 10, and 20 milligram doses of the drug for major depression, The Associated Press reported.
Ivax is part of Teva Pharmaceutical Industries Ltd. of Israel.

The brand name Lexapro is made by New York-based Forest Laboratories Inc. Last year, Lexapro was the No. 2 antidepressant in the United States, with 29.6 million prescriptions filled and sales of $2.1 billion. The drug Zoloft was the leading antidepressant, the AP reported.
Last reviewed: 05/23/2006 Last updated: 05/23/2006

ClickComments

Dr. Group's Secret to Health Kit

Dr. Group's Secret to Health Kit

$39.94
[ learn more ]

Add to Cart

Dr. Group's Secret to Health Kit offers simple at-home solutions for cleansing internally and externally thereby reducing toxins, restoring the body's natural healing process, and helping you achieve true health and happiness.